An MRI result with color gradations shows smaller metastases that current clinical scans might miss.
A new method to detect cancer in its early stages using a targeted MRI contrast agent that binds to proteins has been identified by a team of researchers led by Georgia State University Regents’ Professor Jenny Yang.
In their study, published in the journal Science Advances, Yang and her colleagues at Georgia State and Emory University describe a newly identified biomarker for detection of liver metastases. With current tests like biopsies, cancer in the liver is often detected in advanced stages, which can limit treatment options and lower overall survival rates. The discovery could have wide-ranging impacts, including more effective diagnosis and precision treatment, and less risk to patients.
“This is a game changer. It has the possibility to have many more applications, really for any type of cancer,” said Yang. “We are already applying it to 10 different types of cancer in the lab.”
The researchers, whose work is funded by the National Cancer Institute, developed an agent that can target certain receptors — in this case, chemokine receptor 4 (CXCR4). The receptor is overexpressed in common metastasis organs, such as the liver, among people who have cancer.
The CXCR4 targeted protein-based MRI contrast agent is expected to overcome major barriers in early diagnosis by showing even tiny instances of cancer cells on multi-color scans called precision MRI (pMRI), a new imaging methodology.
Using MRI technology, contrast agents carry the element gadolinium to enhance the images. During her previous work analyzing calcium, Yang decided to test how a metal, like gadolinium, would interact with protein. The protein wraps around the element and carries it to the site for imaging. Yang’s team found that protein design is much more effective in targeting the signs of disease.
“Currently, it is difficult to see early stages of disease in the liver, even in invasive biopsy,” said Yang. “Diagnostic testing using this contrast agent can not only identify the presence of disease but differentiate the stages of disease with high sensitivity and accuracy. That’s the beauty of this work.”
The findings are so promising, the targeted protein contrast agent is now being fast-tracked by the U.S. Food and Drug Administration (FDA) in the first step toward clinical trials to gauge its efficacy in humans.
“We have already met with the FDA, so we have a blueprint,” said Yang. “We hope within 18 months to two years we can conduct our first clinical trials in patents.”
Yang, who is also the associate director of the Center for Diagnostics and Therapeutics, holds 17 U.S. and 18 foreign patents in protein engineering. She recently became the university’s first professor to be awarded a fellowship by the National Academy of Inventors. Her start-up company InLighta Biosciences has been a key channel to allow her to compete for important funding and bring new discoveries to the marketplace.
The research builds on a 2019 study published in the journal Nature Communications, in which Yang’s team identified the first early detection of liver fibrosis using a collagen-targeted protein contrast agent. Combined, these studies represent the work of more than a dozen scientists from universities across the U.S., and their discoveries could help transform a $300 million industry that has seen few advances in the past several decades.
“We have been using the same contrast agents for 30 years with few breakthroughs,” said Yang. “I think this is my biggest scientific contribution. And I hope there are many more to come.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Detecting early-stage cancer
- A blood test to help detect lung cancer? New test offered at OSF Healthcare part of trend in medicine
Julie Harris had never been tested for lung cancer. A low-dose CT scan, the only recommended screening for adults at risk of developing lung cancer, was not something she’d ever found time to do. But ...
- Oral Microbiome Test Could Detect Gastric Cancer Earlier
An oral rinse shows distinct differences in the microbiomes of people with pre-gastric or gastric cancer compared with controls, suggesting the possibility of a new tool for early detection.
- New oral rinse could help detect gastric cancer in early stages
Researchers say a simple "swish and spit" oral rinse may be able to detect changes in a person's microbiome that could help diagnose gastric cancer in its earlier stages ...
- Oral rinse shows promise in early detection of gastric cancer
A simple oral rinse could provide early detection of gastric cancer, the fourth-leading cause of cancer deaths worldwide, according to a study scheduled for presentation at Digestive Disease Week (DDW ...
- A simple ‘swish-and-spit’ test might be able to detect cancer
Swish your way to early cancer detection? Researchers at Rutgers believe a simple oral rinse may be key to the early detection of gastric cancer, also known as stomach cancer. In a study scheduled for ...
Go deeper with Google Headlines on:
Detecting early-stage cancer
[google_news title=”” keyword=”detecting early-stage cancer” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Detecting cancer
- Understanding the signs and symptoms of bladder cancer, and what you can do to minimize risk
Dr. Zin W. Myint University of Kentucky Kentucky has one of the highest rates of new cancers in the U.S., with bladder cancer in the top ten list of new diagnoses. Understanding the signs, risk ...
- Miraculous new cancer treatment gives New Jersey mom a chance for second baby
A New Jersey mom had just given birth when she received a life-changing cancer diagnosis — and her biggest fear was she wouldn’t be able to have more children. When Kelly Spill first started ...
- Aroostook breast cancer detection innovator vies for statewide business award
Kendra Batchelder, co-founder and CEO of Waved Medical LLC in Presque Isle, is one of two County entrepreneurs set to compete for $25,000 in the state Top Gun Showcase Pitch Event on May 16 in ...
- A blood test to help detect lung cancer? New test offered at OSF Healthcare part of trend in medicine
Julie Harris had never been tested for lung cancer. A low-dose CT scan, the only recommended screening for adults at risk of developing lung cancer, was not something she’d ever found time to do. But ...
- Oral Microbiome Test Could Detect Gastric Cancer Earlier
An oral rinse shows distinct differences in the microbiomes of people with pre-gastric or gastric cancer compared with controls, suggesting the possibility of a new tool for early detection.
Go deeper with Google Headlines on:
Detecting cancer
[google_news title=”” keyword=”detecting cancer” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]